Toxoplasmosis, Cerebral
Information
- Disease name
- Toxoplasmosis, Cerebral
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00000643 | Completed | Phase 2 | Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients | May 1994 | |
| NCT00000666 | Completed | N/A | A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection | March 1992 | |
| NCT00000674 | Completed | N/A | A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS | August 1992 | |
| NCT00000794 | Completed | Phase 2 | Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis | April 1998 | |
| NCT00000966 | Completed | Phase 1 | A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS | ||
| NCT00000973 | Completed | Phase 1 | A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients | March 1995 | |
| NCT00001994 | Completed | N/A | A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine | ||
| NCT00002064 | Completed | N/A | Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse | ||
| NCT04341155 | Recruiting | Phase 2 | Dexamethasone for Cerebral Toxoplasmosis | April 16, 2021 | July 2024 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016781